[XENE] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 22.17%
YoY- -52.50%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 264 15 16 376 413 413 601 -42.18%
PBT -7,742 -7,380 -7,517 -6,004 -7,714 -6,016 -3,263 77.79%
Tax -902 -513 -470 542 383 -350 -2,395 -47.81%
NP -7,742 -7,380 -7,517 -6,004 -7,714 -6,016 -3,263 77.79%
Tax Rate - - - - - - - -
Total Cost 8,006 7,395 7,533 6,380 8,127 6,429 3,864 62.45%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -2,932.58 -49,200.00 -46,981.25 -1,596.81 -1,867.80 -1,456.66 -542.93 207.53%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -0.43 -0.41 -0.42 -0.33 -0.51 -0.42 -0.23 51.70%
EPS Diluted -0.43 -0.41 -0.42 -0.33 -0.51 -0.42 -0.23 51.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.